Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 2Recruiting 2Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17Breast 16Genitourinary 12Thoracic 8Other hematologic neoplasm 5Head & Neck 5Gynecologic 5Tumor-Agnostic 4Lymphoid 4CNS 4Sarcoma 2Plasma cell 2Other solid neoplasm 2Other 1Myeloid 1Endocrine 1

Conditions

Obesity 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1

Interventions

Exercise 4Methods 2Educational Status 2Early Intervention, Educational 2Counseling 2semaglutide 1dexamethasone acetate 1dexamethasone 21-phosphate 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1auricularum 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Ultrasonic Waves 1Topiramate 1Tirzepatide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Robotic Surgical Procedures 1Resistance Training 1Qsymia 1Physical Examination 1Phentermine 1Parturition 1Naltrexone 1Liraglutide 1Interviews as Topic 1Glucagon-Like Peptide-1 Receptor 1Fluorescence Polarization Immunoassay 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Standard of Care × Other × Clear all
NCT04175678 2026-03-10

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase NA Active not recruiting
100 enrolled
EndocrineOther

Motor Activity, Obesity, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡